Florida healthcare exec convicted in $1.3B fraud case

Philip Esformes, who operated a network of more than 30 skilled nursing homes and assisted living facilities in Florida, was found guilty April 5 of 20 charges, including paying and receiving kickbacks, money laundering and bribery, according to the Department of Justice.

Advertisement

Mr. Esformes was convicted after an eight-week trial for his role in a $1.3 billion Medicare and Medicaid fraud case, which was one of the largest healthcare fraud schemes ever charged by the Justice Department.

According to evidence presented at trial, Mr. Esformes bribed physicians to admit patients into his facilities. Once admitted, some patients received medically unnecessary care that was billed to Medicare and Medicaid, according to prosecutors.

Mr. Esformes was one of three defendants charged in an indictment unsealed in July 2016 for their alleged involvement in the fraud scheme that began in January 1998. He allegedly received more than $37 million from the scam.

Mr. Esformes’ lawyers said they plan to file an appeal in the case, according to The Hill.

More articles on legal and regulatory issues:

5 latest healthcare industry lawsuits, settlements
Former hospital exec sues Tenet, claims retaliation for reporting unnecessary surgeries
Fresenius will pay $231M to settle bribery charges

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.